BridgeBio Oncology Therapeutics, Inc. BBOT
- BBO-11818 — Non-Small Cell Lung Cancer Phase 1
- BBO-11818 — Colorectal Cancer Phase 1
- BBO-11818 — Pancreatic Ductal Adenocarcinoma Phase 1
KRAS G12V (1 companies · 3 programs)
Companies with an active program directed at KRAS G12V.